Please use this identifier to cite or link to this item: https://doi.org/10.1111/jgh.15346
Title: Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey
Authors: Oshima, Tadayuki
Siah, Kewin Tien Ho 
Yoshimoto, Takanori
Miura, Ko
Tomita, Toshihiko
Fukui, Hirokazu
Miwa, Hiroto
Keywords: Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
COVID-19
Functional dyspepsia
Functional gastrointestinal disorders
Irritable bowel syndrome
Psychological disease
SARS-CoV-2
ROME III CRITERIA
GASTROINTESTINAL DISORDERS
HOSPITAL ANXIETY
SCALE
EPIDEMIOLOGY
VALIDITY
HEALTH
JAPAN
ABUSE
LIFE
Issue Date: 1-Dec-2020
Publisher: WILEY
Citation: Oshima, Tadayuki, Siah, Kewin Tien Ho, Yoshimoto, Takanori, Miura, Ko, Tomita, Toshihiko, Fukui, Hirokazu, Miwa, Hiroto (2020-12-01). Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 36 (7) : 1820-1827. ScholarBank@NUS Repository. https://doi.org/10.1111/jgh.15346
Abstract: Background and Aim: Functional gastrointestinal disorders are a group of stress-sensitive gut–brain disorders. The COVID-19 outbreak has caused immense stress and anxiety among the general public. Strict measures to counter COVID-19 emergency, including physical distancing, have also taken a toll on physical and mental health. We investigated the impact of the COVID-19 pandemic on the gastrointestinal and psychological symptoms of functional dyspepsia (FD) and irritable bowel syndrome (IBS). Methods: An online survey was conducted in Japan for a group of randomly assigned panelists from May 26 to 27, 2020. Each respondent answered a questionnaire on stress, physical distancing, and worries about COVID-19. Gastrointestinal symptoms were assessed to diagnose FD and IBS (Rome III), and psychological symptoms were assessed using the Hospital Anxiety and Depression Scale. Results: A total of 5157 subjects were finally enrolled, with FD in 8.5%, IBS in 16.6%, and FD–IBS overlap in 4.0%. For both gastrointestinal and psychological symptoms, respondents with FD–IBS overlap showed the worst scores, followed by IBS-alone, then FD-alone respondents. During the COVID-19 pandemic, 11.9% of respondents reported deterioration and 2.8% reported improvement of gastrointestinal symptoms. FD–IBS overlap, psychological disease comorbidity, and stress at work/school were significantly associated with symptom deterioration. Younger age, commuting by public transport, and work/study from home were associated with symptom improvement. Conclusions: The COVID-19 pandemic negatively affected FD/IBS subjects, with respondents showing FD–IBS overlap syndrome as the most important independent factor associated with deterioration in gastrointestinal symptoms. Physicians need to take extra care of FD/IBS patients in the post-COVID period.
Source Title: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
URI: https://scholarbank.nus.edu.sg/handle/10635/206722
ISSN: 08159319
14401746
DOI: 10.1111/jgh.15346
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome A population-based survey.pdf731.66 kBAdobe PDF

CLOSED

None

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.